NCT01354782View on ClinicalTrials.gov

Pharmacokinetic Study of Single and Repeated Dose of Roflumilast 500 µg , in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

June 30, 2011

Study Completion Date

September 30, 2011

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG

Roflumilast

"Period I: single dose of roflumilast 500 μg orally in the morning.~Period II: repeated dose of roflumilast 500 μg orally in the morning for 14 days."

Trial Locations (1)

100032

Nycomed Investigational Site, Beijing